EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ToF ‐ SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma

Noora Neittaanmäki iD, Oscar Zaar, Kevin Sjögren Cehajic, Kelly Dimovska Nilsson, Dimitrios Katsarelias, Roger Olofsson Bagge, John Paoli, John S Fletcher

Pigment Cell & Melanoma Research · 2024-11 · 37 (6) · 793-800

DOI: 10.1111/pcmr.13182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 29.06.2024. Verfasst von Noora Neittaanmäki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Melanoma, Spectrometry, Mass, Secondary Ion, Disease Progression, Skin Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish state, Swedish Research Council, Vetenskapsrådet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most melanomas progress from radial to vertical growth phase before spreading locoregionally and distally. Much is still unknown about the metabolic changes in the tumor cells and their microenvironment during this metastatic progression. We aimed to gain new insight into the molecular characteristics of melanoma in regard to spatial lipidomics to deliver new knowledge regarding tumor metastatic progression. We included 10 fresh tumor samples from 10 patients including two in situ melanomas, two invasive primary melanomas, and six metastatic melanomas (four in‐transit metastases and two distant metastases). In addition, we analyzed four healthy skin controls from the same patients. Time‐of‐flight imaging secondary ion mass spectrometry (ToF‐SIMS) enabled detailed spatial‐lipidomics that could be directly correlated with conventional histopathological analysis of consecutive H&E‐stained tissue sections. Significant differences in the lipid profiles were found in primary compared to metastatic melanomas, notably an increase in phosphatidylethanolamine lipids relative to phosphatidylinositol lipids and an increase in GM3 gangliosides in the metastatic samples. Furthermore, analysis of the data from in transit versus distant metastases samples highlighted that specific phospholipids, and a difference in the long versus shorter chain GM3 gangliosides, discriminated the metastatic routes. Further studies are warranted to verify these preliminary findings. Lipidomic changes could serve as a novel biomarker for tumor progression and even serve as a target for novel treatments. Furthermore, analyzing the lipid profiles could help to differentiate between primary and metastatic melanomas in challenging cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSpectrometry, Mass, Secondary IonDisease ProgressionSkin NeoplasmsNeoplasm MetastasisHumansMaleFemaleLipidomicsLipidsMiddle AgedLipid MetabolismAged

Stichwörter der Autor:innen

chemical imaginglipidomicsmelanomametastatic progressiontime‐of‐flight imaging secondary ion mass spectrometry

Substanzen

Lipids

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Clinical Pathology and Cytology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Dermatology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
  • Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Noora Neittaanmäki

Förderung

  • Swedish state
  • Swedish Research Council
  • Vetenskapsrådet

Zitieren

APA

Neittaanmäki, N., Zaar, O., Cehajic, K. S., Nilsson, K. D., Katsarelias, D., Bagge, R. O., Paoli, J., & Fletcher, J. S. (2024). ToF ‐ SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma. Pigment Cell & Melanoma Research, 37(6), 793-800. https://doi.org/10.1111/pcmr.13182

Vancouver

Neittaanmäki N, Zaar O, Cehajic KS, Nilsson KD, Katsarelias D, Bagge RO, et al. ToF ‐ SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma. Pigment Cell & Melanoma Research. 2024;37(6):793-800. doi:10.1111/pcmr.13182

BibTeX
@article{Neittaanmki2024,
  author = {Neittaanmäki, Noora and Zaar, Oscar and Cehajic, Kevin Sjögren and Nilsson, Kelly Dimovska and Katsarelias, Dimitrios and Bagge, Roger Olofsson and Paoli, John and Fletcher, John S},
  title = {ToF ‐ SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma},
  journal = {Pigment Cell & Melanoma Research},
  year = {2024},
  volume = {37},
  number = {6},
  pages = {793--800},
  doi = {10.1111/pcmr.13182}
}
Kostenlos starten →